2465 — Leadtek Research Income Statement
0.000.00%
- TWD4.00bn
- TWD4.11bn
- TWD4.30bn
Annual income statement for Leadtek Research, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,548 | 8,823 | 5,311 | 4,276 | 4,296 |
Cost of Revenue | |||||
Gross Profit | 563 | 1,570 | 607 | 628 | 368 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,495 | 8,269 | 5,464 | 4,375 | 4,727 |
Operating Profit | 53.1 | 554 | -152 | -98.5 | -431 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 54.7 | 546 | -201 | -133 | -433 |
Provision for Income Taxes | |||||
Net Income After Taxes | 24.8 | 435 | -196 | -160 | -440 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26.8 | 435 | -196 | -160 | -441 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 26.8 | 435 | -196 | -160 | -441 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.437 | 7.37 | -3.31 | -2.53 | -5.25 |
Dividends per Share |